We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News   Oct 19, 2017

 
Quotient Clinical Signs Cocrystal Agreement with Nuformix
 
 
Advertisement
 

RELATED ARTICLES

Novel Role of Immune System in Psoriasis

News

Scientists have uncovered another one of the complex immune-mediated mechanisms behind the onset of psoriasis and severe psoriasis lesions. The work highlights potential therapeutic targets for future treatments.

READ MORE

Trial Results Address Concerns About Pharmacogenetic Testing

News

Some laboratories now offer pharmacogenetic tests that allow patients to learn whether they carry genetic variants known to be associated with adverse drug effects. But there have been concerns. A new paper published in JAMA Network Open might help allay some of these concerns.

READ MORE

Peanut Allergy Treatment Shown To Significantly Reduce Risk of Life-Threatening Reactions

News

After one year of treatment, almost 80 percent of study participants were able to eat 15 peanuts without a reaction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE